Voloridge Investment Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-156,256
Closed -$3.55M 1567
2022
Q4
$3.55M Sell
156,256
-246,409
-61% -$6.86M 0.02% 778
2022
Q3
$13.7M Buy
+402,665
New +$14.9M 0.07% 359
2022
Q2
Sell
-53,899
Closed -$1.44M 1595
2022
Q1
$1.44M Buy
+53,899
New +$1.27M 0.01% 1046

Other funds holding PRVA

Voloridge Investment Management's PRVA Position: Q1 2023 in Review

Voloridge Investment Management sold out of Privia Health (PRVA) in Q1 2023, closing a stake of 156,256 shares — an estimated $3.55M sold.

Voloridge Investment Management first reported a position in PRVA in Q1 2022 and held it in 3 quarters. The position peaked at $13.7M in Q3 2022. 191 funds tracked by Wall St. Rank hold PRVA as of Q1 2023.

  • Voloridge Investment Management reported no remaining Privia Health position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 156,256 Privia Health shares in Q1 2023, an estimated $3.55M.
  • Voloridge Investment Management first reported a position in Privia Health in Q1 2022 and held it in 3 quarters.
  • Voloridge Investment Management's Privia Health position peaked at $13.7M in Q3 2022.
  • 191 funds tracked by Wall St. Rank held Privia Health as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.